These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 606788)

  • 41. Influenza immunization of children with neoplastic diseases.
    Steinherz PG; Brown AE; Gross PA; Braun D; Ghavimi F; Wollner N; Rosen G; Armstrong D; Miller DR
    Cancer; 1980 Feb; 45(4):750-6. PubMed ID: 7357492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
    Vesikari T; Pellegrini M; Karvonen A; Groth N; Borkowski A; O'Hagan DT; Podda A
    Pediatr Infect Dis J; 2009 Jul; 28(7):563-71. PubMed ID: 19561422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults.
    Dolin R; Wise TG; Mazur MH; Tuazon CU; Ennis FA
    J Infect Dis; 1977 Dec; 136 Suppl():S435-42. PubMed ID: 342618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants.
    Wright PF; Sell SH; Thompson J; Karzon DT
    J Pediatr; 1976 Jan; 88(1):31-5. PubMed ID: 1245939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acceptibility and antigenicity of influenza A/Victoria/75 virus vaccines in adults of different ages.
    Gwaltney JM; Adams KF; Hendley JO
    J Infect Dis; 1977 Dec; 136 Suppl():S491-5. PubMed ID: 606770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live attenuated influenza virus vaccine trial in children.
    Hall CB; Douglas G; Fralonardo SA
    Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intradermal administration of bivalent and monovalent influenza vaccines.
    Brooks JH; Criep LH; Ruben FL
    Ann Allergy; 1977 Aug; 39(2):110-2. PubMed ID: 889154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.
    Boyer KM; Cherry JD; Noble GR
    Dev Biol Stand; 1977 Jun 1-3; 39():303-8. PubMed ID: 604113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response of normal children to influenza A/New Jersey/76 virus vaccine administered by jet injector.
    McIntosh K; Orr I; Andersen M; Arthur JH; Blakeman GJ
    J Infect Dis; 1977 Dec; 136 Suppl():S584-7. PubMed ID: 606775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant.
    Sumaya CV; Gibbs RS
    J Infect Dis; 1979 Aug; 140(2):141-6. PubMed ID: 479636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-related heterologous antibody responses to influenza virus vaccination.
    Noble GR; Kaye HS; Kendal AP; Dowdle WR
    J Infect Dis; 1977 Dec; 136 Suppl():S686-92. PubMed ID: 606792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and immunogenicity of a paediatric presentation of an influenza vaccine.
    Gonzalez M; Pirez MC; Ward E; Dibarboure H; García A; Picolet H
    Arch Dis Child; 2000 Dec; 83(6):488-91. PubMed ID: 11087282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization against swine influenza in the Yale University Community.
    Evans AS; Kraus G
    Yale J Biol Med; 1978; 51(2):165-76. PubMed ID: 210597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW; Contreras G; Furesz J
    Can Med Assoc J; 1979 Apr; 120(7):799-802, 831. PubMed ID: 427686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T; Richmond PC; Formica NT; Höschler K; Skeljo MV; Stoney T; McVernon J; Hartel G; Sawlwin DC; Bennet J; Ryan D; Basser RL; Zambon MC
    Vaccine; 2008 Nov; 26(50):6383-91. PubMed ID: 18801398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia.
    Lange B; Shapiro SA; Waldman MT; Proctor E; Arbeter A
    J Infect Dis; 1979 Sep; 140(3):402-6. PubMed ID: 291662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.